Legal Representation
Attorney
Lisa M. Dellamura
USPTO Deadlines
Next Deadline
69 days remaining
Final Refusal E-Mailed
Due Date
November 18, 2025
Extension Available
Until February 18, 2026
Application History
17 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 18, 2025 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Aug 18, 2025 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Aug 18, 2025 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Aug 18, 2025 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
| Aug 11, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 1, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 1, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 1, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 31, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 31, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 31, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 29, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 22, 2025 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Jul 22, 2025 | TAEA | I | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | Loading... |
| May 14, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| May 14, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 14, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations
Classification
International Classes
005